Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult Participants
Clinical trial NCT05824143 · COMPLETED
Trial details
- NCT number
- NCT05824143
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2023-07-07
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.